[Impact of dyslipidemia on the onset and progression of diabetic complications]

Nihon Jinzo Gakkai Shi. 2013;55(7):1280-6.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Cerebrovascular Disorders / etiology
  • Cerebrovascular Disorders / prevention & control
  • Coronary Disease / etiology*
  • Coronary Disease / prevention & control
  • Diabetic Angiopathies / etiology*
  • Diabetic Angiopathies / prevention & control*
  • Diabetic Nephropathies / etiology*
  • Diabetic Nephropathies / prevention & control*
  • Dyslipidemias / complications*
  • Dyslipidemias / metabolism
  • Fenofibrate / administration & dosage
  • Glomerular Filtration Rate
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hypolipidemic Agents / administration & dosage
  • Insulin / physiology
  • Risk Factors

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Insulin
  • Fenofibrate